Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$440K Buy
7,613
+169
+2% +$9.53K 0.04% 230
2018
Q1
$385K Buy
7,444
+1,287
+21% +$69.5K 0.04% 245
2017
Q4
$330K Sell
6,157
-215
-3% -$11.9K 0.03% 252
2017
Q3
$388K Buy
6,372
+377
+6% +$22.9K 0.04% 239
2017
Q2
$366K Sell
5,995
-26,352
-81% -$1.6M 0.04% 246
2017
Q1
$1.96M Buy
32,347
+748
+2% +$45.4K 0.24% 94
2016
Q4
$1.77M Buy
+31,599
New +$1.85M 0.23% 109

Other funds holding MRK

Edge Advisors's MRK Position: Q2 2018 in Review

Edge Advisors increased its Merck (MRK) stake by 2.3% in Q2 2018, buying an estimated $9.53K and bringing the position to 7,613 shares worth $440K. The position accounts for 0.04% of the portfolio, ranked #230.

Edge Advisors first reported a position in MRK in Q4 2016 and has held it in 7 quarters since. The position peaked at $1.96M in Q1 2017. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

  • Edge Advisors held 7,613 shares of Merck worth $440K as of Q2 2018.
  • Edge Advisors bought 169 Merck shares in Q2 2018, an estimated $9.53K.
  • Merck made up 0.04% of Edge Advisors's portfolio in Q2 2018, its #230 holding.
  • Edge Advisors first reported a position in Merck in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Merck position peaked at $1.96M in Q1 2017.
  • 2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.